United States· US:71335-2540_f0974f5e-83f9-4296-bf0d-535f2edfaa08

Glipizide

A glipizide product containing glipizide, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 8 of our 19 countries.

In shortageATC A10BB07Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGlipizideATCA10BB07REGISTER NO.US:71335-2540_f0974f5…PACKS LISTED7CHECKEDSeptember 12, 2026

Where it is registered

Glipizide is registered in 8 of 19 countries.

Countries holding a registration under ATC A10BB07 (glipizide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Glipizide · ATC A10BB07

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Italyprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glipizide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.056 in United States to $0.39 in France — a ×7.0 gap.

  • United States: $0.056 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Glipizide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • FR France$0.39
  • IT Italy$0.32
  • US United States$0.056 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Glipizide
Manufacturer
Bryant Ranch Prepack
Country
United States (US)
ATC code
A10BB07
ATC class
Glipizide
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 7

  • ndc11
    7133525401
    60 TABLET in 1 BOTTLE (71335-2540-1)
  • ndc11
    7133525402
    30 TABLET in 1 BOTTLE (71335-2540-2)
  • ndc11
    7133525403
    100 TABLET in 1 BOTTLE (71335-2540-3)
  • ndc11
    7133525404
    120 TABLET in 1 BOTTLE (71335-2540-4)
  • ndc11
    7133525405
    90 TABLET in 1 BOTTLE (71335-2540-5)
  • ndc11
    7133525406
    20 TABLET in 1 BOTTLE (71335-2540-6)
  • ndc11
    7133525407
    180 TABLET in 1 BOTTLE (71335-2540-7)

Regulatory notes

UNII (FDA substance ID)
X7WDT95N5C
GLIPIZIDE
RxCUI 4821
Orange Book
A214874
ABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Glipizide Tablet, Extended Release

Interactions

745 interactions on record for glipizide.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glipizide · interactions on record

745 records

  • 20 severe
  • 448 moderate
  • 51 minor
  • 226 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glipizide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glipizide products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Czechia · Minidiab
  • Spain · Minodiab
  • France · Ozidia
  • United Kingdom (Northern Ireland) · Minodiab
  • Italy · Minidiab
  • Poland · Glipizide Bp Galena
  • Romania · Glucotrol Xl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5a50627-7845-47a2-9e67-49b8d2cb48c6
GET /v1/drugs/d5a50627-7845-47a2-9e67-49b8d2cb48c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "X7WDT95N5C",
    "rxcui": "4821",
    "inchikey": "ZJJXGWJIGJFDTL-UHFFFAOYSA-N",
    "display_name": "GLIPIZIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 3
  },
  "spl_meta": {
    "9b405ff3-6ce5-460a-9406-db92e0e6ab1b": {
      "match": "brand_token",
      "title": "GLIPIZIDE TABLET [BRYANT RANCH PREPACK]",
      "spl_version": "1",
      "published_date": "2026-05-25"
    }
  },
  "productid": "71335-2540_f0974f5e-83f9-4296-bf0d-535f2edfaa08",
  "productndc": "71335-2540",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "214874",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": null,
        "strength": "2.5MG",
        "product_no": "001",
        "approval_date": "Oct 3, 2023"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "5MG",
        "product_no": "002",
        "approval_date": "Oct 3, 2023"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "10MG",
        "product_no": "003",
        "approval_date": "Oct 3, 2023"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": null,
        "strength": "15MG",
        "product_no": "004",
        "approval_date": "Feb 4, 2026"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "GLIPIZIDE",
  "shortage_reason": "Glipizide Tablet, Extended Release",
  "shortage_status": "current",
  "proprietary_name": "Glipizide",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA214874",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Glipizide",
  "start_marketing_date": "20231003",
  "active_numerator_strength": "10"
}

See everything about glipizide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.